pretti end right move sell medic aesthet
summari take-away
wednesday novemb announc intend sell cynosur medic
aesthet busi clayton dubili rice privat equiti firm total purchas
price million cash net million account close adjust
view divestitur long time come put end bad marriag
began acquir asset sinc day one street skeptic
manag would clean long troubl asset find way
chang busi model leverag call point quickli post-clos
difficulti task becam clear team fought hard last year tri
right ship doubt qualiti intern busi improv
revenu profit never caught caus extend overhang revenu
earn growth well investor sentiment believ impair
multipl busi fulli support team decis walk away
troubl asset turn effort back core pillar made success
focu point investor last sever month believ
execut area biggest driver share price
overhang remov
background cynosur acquir februari billion net cash
intent help diversifi away core area breast
diagnost also relationship obgyn practic sometim desir
offer cash pay servic howev almost immedi cynosur acquisit came
pressur increas competit offer salesforc integr issu hard hit
fda warn public use energy-bas devic perform
vagin rejuven vagin cosmet procedur despit blow team seem
determin implement turnaround initi believ would help busi
return double-digit top-lin growth effort clearli work roughli six
month ago team began formal process divest asset receiv sever
bid highest cours would like team get
time revenu asset note holog
posit strength negoti mind believ
import take-away sale compani formal move
chapter doubl tuck-in strategi serv well
return equiti ttm
develop manufactur medic imag system product emphasi women health
busi unit focus breast health diagnost gynecolog surgeri aesthet skelet health
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
stock standpoint last month said potenti sale cynosur could serv modest catalyst
share said team call combin earn accret come transact newli
announc acceler repurchas program million believ alon caus share acceler
meaning believ bit conserv given cynosur mayb net incom break-even asr could
penni two impact even still modestli increas earn growth rate
addit math assum fxn growth medic aesthet show could add much basi
point total top-lin fxn growth rate coupl believ sever area potenti conservat
model could mean growth year come higher end current fxn revenu growth rang howev
given less two month fiscal year hold formal call yet expect
chang number modestli
overal posit announc today team move troubl chapter investor shi
away stock due cynosur begin take anoth look said last quarter see
amalgam busi combin form low- midsingle-digit top-lin growth outlook lead earn
growth expect high singl digit mayb doubl digit depend use cash flow coupl strong
free cash flow tuck-in strategi believ stock continu room upsid current valuat time
project ep result reiter outperform rate
overal cynosur busi roughli net break-even net incom annual basi quarter posit other
neg given deal expect close calendar year-end team walk away posit earn
quarter believ help explain lack upsid earn accret annual basi
margin standpoint cynosur roughli basi point dilut corpor gross margin basi point dilut
given difficulti forecast busi annual revenu manag guid materi increas revenu
growth rate year assum estim cynosur accur million fxn remov
revenu period fxn growth estim increas fxn
per custom hold formal updat model transact close
william blair affili market maker secur inc
william blair affili expect receiv intend seek compens invest bank servic inc
affili within next three month
offic employe william blair affili research analyst may financi interest secur
report avail electron form regist user via doc http //williamblairlibrari bluematrix com
pleas contact us consult williamblair com/research-and-insights/equity-research/coverag aspx disclosur
brian weinstein attest view express research report accur reflect his/her person view
secur compani cover report part his/her compens relat directli
indirectli specif recommend view express him/her report seek updat research appropri
certain period industri report major report publish irregular interv deem appropri
inc ra ing hist ori
power bluematrix
op outperform market market perform perform nr rate initi coverag drop coverag
current rate distribut novemb
addit inform avail upon request
percentag compani rate categori invest bank client defin compani william blair
receiv compens invest bank servic within past month
compens research analyst base varieti factor includ perform stock recommend
contribut firm depart includ asset manag corpor financ institut sale retail brokerag firm
profit competit factor
